Hsbc Holdings PLC Precigen, Inc. Transaction History

Hsbc Holdings PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$1.27 - $1.75 $163 - $225	129 Added 0.96%	13,594 $21,000
Q1 2024 May 15, 2024	BUY	$1.21 - $1.75 $16,292 - $23,563	13,465 New	13,465 $19,000
Q3 2020 Nov 12, 2020	SELL	$3.5 - $6.2 $56,395 - $99,900	-16,113 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$2.16 - $5.46 $34,804 - $87,976	16,113 New	16,113 $80,000

143

159M

232K

69K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $179M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.